The FDA approved an oral extended-release formulation of levodopa and carbidopa known as IPX203 (Crexont) to treat Parkinson's disease, Amneal Pharmaceuticals announced Wednesday. The treatment is a ...

The study additionally shows sustained and smooth levodopa levels in the blood stream. Laxxon's LXM.5 can achieve such improved bioavailability and levodopa levels due to the sequential release of the ...

A new research letter published in the journal JAMA Neurology has reported some dietary supplements can contain extraordinarily high levels of a molecule called levodopa, which is often used in drug ...

Report in the Journal of Parkinson's Disease presents data from one-year trial on long-term safety, efficacy, and quality of life in advanced PD patients using levodopa-carbidopa intestinal gel ...

Please provide your email address to receive an email when new articles are posted on . Once-daily opicapone 50 mg with carbidopa/levodopa helped achieve and maintain plasma concentrations of levodopa ...